Recent advancements in swallowable esophageal cell-collection devices (SECD) offer a safe, minimally invasive, accurate, and low-cost alternative to esophageal screening without the need for an upper endoscopy. The BEST-RPP study aims to evaluate the acceptability and feasibility of using this novel approach to screen for Barrett's Esophagus (BE) and Esophageal Carcinoma (EAC) in rural primary care clinic settings in Oregon.
Age range
50 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Feasibility of the use of a SECD: Number of providers who indicate likelihood of using SECD
Timeframe: 8 months
Feasibility of the use of SECD: Number of providers who indicate willingness to be trained and train clinic staff
Timeframe: 8 months
Feasibility of the use of SECD: Number of referrals
Timeframe: 8 months
Feasibility of the use of SECD: Number enrolled
Timeframe: 8 months
Patient acceptability: Number of interested patients who schedule an appointment to be screened
Timeframe: 8 months
Patient acceptability: Number of patients who come to their appointments
Timeframe: 8 months
Patient acceptability: Number of patients interested in being screened via SECD at other care centers
Timeframe: 8 months